These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 17901561

  • 1. Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment.
    Berthiaume JM, Wallace KB.
    Cardiovasc Toxicol; 2007; 7(3):178-91. PubMed ID: 17901561
    [Abstract] [Full Text] [Related]

  • 2. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy.
    Carvalho RA, Sousa RP, Cadete VJ, Lopaschuk GD, Palmeira CM, Bjork JA, Wallace KB.
    Toxicology; 2010 Apr 11; 270(2-3):92-8. PubMed ID: 20132857
    [Abstract] [Full Text] [Related]

  • 3. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
    Zordoky BN, Anwar-Mohamed A, Aboutabl ME, El-Kadi AO.
    Toxicol Appl Pharmacol; 2010 Jan 01; 242(1):38-46. PubMed ID: 19796650
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X, Zhou Z, Kang YJ.
    Cancer Res; 2001 Apr 15; 61(8):3382-7. PubMed ID: 11309296
    [Abstract] [Full Text] [Related]

  • 5. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
    Alsaad AM, Zordoky BN, El-Sherbeni AA, El-Kadi AO.
    Drug Metab Dispos; 2012 Nov 15; 40(11):2126-35. PubMed ID: 22867862
    [Abstract] [Full Text] [Related]

  • 6. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY, Najjar TA, Alashari M.
    J Biochem Mol Toxicol; 2004 Nov 15; 18(2):78-86. PubMed ID: 15122649
    [Abstract] [Full Text] [Related]

  • 7. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
    Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C.
    Cancer Res; 2002 Aug 15; 62(16):4592-8. PubMed ID: 12183413
    [Abstract] [Full Text] [Related]

  • 8. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.
    Sardão VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB.
    Cell Biol Toxicol; 2009 Jun 15; 25(3):227-43. PubMed ID: 18386138
    [Abstract] [Full Text] [Related]

  • 9. Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats--relevance for mitochondrial dysfunction.
    Oliveira PJ, Wallace KB.
    Toxicology; 2006 Mar 15; 220(2-3):160-8. PubMed ID: 16427179
    [Abstract] [Full Text] [Related]

  • 10. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats.
    Zhou S, Heller LJ, Wallace KB.
    Toxicol Appl Pharmacol; 2001 Aug 15; 175(1):60-7. PubMed ID: 11509027
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.
    Richard C, Ghibu S, Delemasure-Chalumeau S, Guilland JC, Des Rosiers C, Zeller M, Cottin Y, Rochette L, Vergely C.
    J Pharmacol Exp Ther; 2011 Dec 15; 339(3):807-14. PubMed ID: 21934029
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acute exercise protects against doxorubicin cardiotoxicity.
    Wonders KY, Hydock DS, Schneider CM, Hayward R.
    Integr Cancer Ther; 2008 Sep 15; 7(3):147-54. PubMed ID: 18815146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.